Hashimoto et al., 2019 - Google Patents
Usefulness of [11C] methionine PET in the differentiation of tumefactive multiple sclerosis from high grade astrocytomaHashimoto et al., 2019
View PDF- Document ID
- 16547209995119181809
- Author
- Hashimoto S
- Inaji M
- Nariai T
- Kobayashi D
- Sanjo N
- Yokota T
- Ishii K
- Taketoshi M
- Publication year
- Publication venue
- Neurologia medico-chirurgica
External Links
Snippet
Tumefactive multiple sclerosis (tumefactive MS) is an atypical variant of MS characterized by a large isolated demyelinating lesion. Because tumefactive MS mimics high grade astrocytoma clinically and radiologically, it is difficult to distinguish between the two using …
- 201000006417 multiple sclerosis 0 title abstract description 59
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sollini et al. | Long COVID hallmarks on [18F] FDG-PET/CT: a case-control study | |
| Shir et al. | Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology | |
| Pauleit et al. | O-(2-[18F] fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas | |
| Webb et al. | The role of 18 F-FDG PET in characterising disease activity in Takayasu arteritis | |
| Schön et al. | Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas | |
| Eide et al. | Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood | |
| Miyake et al. | Usefulness of FDG, MET and FLT‐PET Studies for the Management of Human Gliomas | |
| Hashimoto et al. | Usefulness of [11C] methionine PET in the differentiation of tumefactive multiple sclerosis from high grade astrocytoma | |
| Parbo et al. | Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease | |
| Fayed et al. | Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas | |
| Mishra et al. | Multimodal MR imaging signatures of cognitive impairment in active professional fighters | |
| Idolazzi et al. | 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity | |
| Ikeguchi et al. | Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas | |
| Lin et al. | Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease | |
| Flanagan et al. | [18F]-fluorodeoxyglucose–positron emission tomography in patients with active myelopathy | |
| Jost et al. | Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma | |
| Ogawa et al. | Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma | |
| Valli et al. | VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder | |
| Zhang et al. | Combined quantitative T2 mapping and [18F] FDG PET could improve lateralization of mesial temporal lobe epilepsy | |
| Zhou et al. | Multimodal assessment of brain fluid clearance is associated with amyloid-beta deposition in humans | |
| Okafor et al. | 18F-flortaucipir PET associations with cerebrospinal fluid, cognition, and neuroimaging in mild cognitive impairment due to Alzheimer’s disease | |
| Fuss et al. | Metabolic imaging in humans | |
| Chiba et al. | Precise detection of the germinomatous component of intracranial germ cell tumors of the basal ganglia and thalamus using placental alkaline phosphatase in cerebrospinal fluid | |
| Sotolongo-Grau et al. | Association between cell-bound blood amyloid-β (1-40) levels and hippocampus volume | |
| Tuntiyatorn et al. | Apparent diffusion coefficients in evaluation of pediatric brain tumors. |